28 April 2023
Riber’s Q1 revenue up 54% year-on-year
For first-quarter 2023, Riber S.A. of Bezons, France – which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources – has reported revenue of €3.7m, up 54% on €2.4m a year ago.
MBE systems revenue was €1.9m (comprising billing for one research system), compared with nil a year ago.
Services & Accessories revenue has fallen by 23% from €2.4m to €1.8m.
Of total revenue, 15% came from Europe, 27% in Asia, 6% in North America and 51% in other countries.
Order book up 45% year-on-year
The order book totaled €33.1m at the end of March, up 45% from €22.8m at end-March 2022, driven by the increase in industrial demand for both R&D and production.
Specifically, orders for MBE systems are up by 60% from €16.7m to €26.7m, comprising 11 machines (including four production machines). This does not include the option to buy, announced on 8 June 2022, for four production machines. The Services & Accessories order book is up 5% from €6.2m to €6.5m.
Full-year outlook for 2023
In view of the strong order book (with a high proportion of machines deliverable in 2023), Riber is targeting full-year revenue of about €40m (up 44% on 2022’s €27.8m). This growth should be combined with an improvement in profitability.
Riber expects that, in a buoyant market context, it will continue taking orders during second-quarter 2023.